About Conference
Hilaris Conferences invites you to be a part of the Blood Cancer Congress 2019 in Paris, France on September 26-27, 2019. Blood Cancer will awareness the latest and exciting transformation in related areas of cancer and it will offer a unique opportunity for investigators from all over the globe to meet, network, and perceive new scientific communications. Cancer is blood cells of Leukemia mainly it starts in Bone Marrow. Hilaris Conferences through the Blood Cancer Congress 2019 Discovering Blood Cancer disorders and other Cancer Conditions, involves a team of healthcare professionals, of which the Blood Cancer research will play a key role with the theme of
“Blood Cancer and its Treatment”
Blood Cancer Congress 2019 will focus the latest and exciting modernization in related areas of cancer and it will offer a unique opportunity for investigators from all over the world to meet, network, and perceive new scientific interactions. Leukemia is cancer of the blood cells. It starts in the bone marrow, the soft tissue inside most bones. Bone marrow is where blood cells are made. When you have blood cancer and leukemia, the bone marrow starts to make a lot of irregular white blood cells, known as leukemia cells. An approximate grand total of 156,420 people is expected to be diagnosed with leukemia in 2014. In recent cases of blood cancer are estimated to account for around 10% of the total blood cancer cases which were diagnosed in 2014
People who can be an audience at Blood Cancer Congress 2019
- Blood cancer researchers
- Hematologists
- Cancer Specialists
- Oncologists
- Medical Oncologists
- Immunologists
- Pathologists
- Research Scholars
- Industrial professionals
- Medical Students
- Nurse Practitioners
- Principle Investigators & Directors
- Laboratory Researchers
- Group Leaders
- Cancer Diagnostic Professionals
- Cancer & Oncology Societies Professionals
- Bio-Medical Company professionals
- Healthcare Industries
- Directors of Association and Societies
- Researchers, Training Institutes
Special Issues
- All accepted abstracts will be published in respective Supporting International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
See more at: https://www.hilarisconferences.com/blood-cancer
